crizanlizumab

Summary

crizanlizumab is a monoclonal antibody^[1]. crizanlizumab draws 23 Wikipedia views per month (monoclonal_antibody category, ranking #10 of 31).^[2]

Key Facts

• crizanlizumab's instance of is recorded as monoclonal antibody^[3].
• crizanlizumab's CAS Registry Number is recorded as 1690318-25-2^[4].
• crizanlizumab's Guide to Pharmacology Ligand ID is recorded as 10550^[5].
• crizanlizumab's UNII is recorded as L7451S9126^[6].
• crizanlizumab's KEGG ID is recorded as D11480^[7].
• crizanlizumab's DrugBank ID is recorded as DB15271^[8].
• crizanlizumab's medical condition treated is recorded as vaso-occlusive crisis^[9].
• crizanlizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'crizanlizumab'}^[10].
• crizanlizumab's Google Knowledge Graph ID is recorded as /g/11c5wmd_18^[11].
• crizanlizumab's World Health Organisation international non-proprietary name numeric ID is recorded as 10316^[12].
• crizanlizumab's active ingredient in is recorded as Adakveo^[13].
• crizanlizumab's MedlinePlus drug identifier is recorded as a620010^[14].
• crizanlizumab's WikiProjectMed ID is recorded as Crizanlizumab^[15].

Why It Matters

crizanlizumab draws 23 Wikipedia views per month (monoclonal_antibody category, ranking #10 of 31).^[2] crizanlizumab has Wikipedia articles in 7 language editions, a strong signal of global cultural recognition.^[16]